Ovasave Secures $1.2M to Revolutionise Women’s Health in the Middle East

Ovasave, a rising star in the FemTech space and part of Abu Dhabi’s Hub71 community, has just closed a hefty $1.2 million pre-seed round. The fundraising was led by a real mixed bag of regional and international investors, with standout names like PlusVC, Annex Investments, and the New York-based 25 Madison at the helm. They weren’t alone—there was a fair bit of support from angel investors and family offices, mostly hailing from the UAE and Saudi Arabia.

If you’ve spent any time with startups in the region, you’ll know how energising it feels when big money backs genuine solutions—especially those that take on hot-button issues like women’s health. Here at Arageek, we always chat about how much untapped potential there is when it comes to innovation aimed at women, particularly in areas people don’t openly discuss. Ovasave is spot on in tackling fertility and hormonal health, shifting the conversation from hush-hush to centre stage.

So, what’s next for the team with this injection of capital? Ovasave has its sights set on scaling across the GCC, beefing up their partnerships with corporates, and rolling out an even better version of their mobile app. The upcoming features seem to pack a punch—think menstrual cycle tracking, symptom monitoring, and AI-powered treatment recommendations. Not exactly your run-of-the-mill health app.

Abu Dhabi seems an ideal launchpad for them, given the government’s real push for reforms in both healthcare and women’s rights. Ovasave’s co-founder, Majd Abu Zant, mentioned that the city’s blend of tough regulation, easy access to decision-makers, and a dynamic tech ecosystem gave their startup a leg up. On the flip side, the UAE’s bigger vision for digital health fits like a glove with Ovasave’s proactive (not just reactive) approach to women’s health.

Co-founder and CEO Torkia Mahloul made it clear: women in the region need quicker access to interventions around fertility and hormones. This latest round not only gives their mission a nudge but sets the stage for expanding into Saudi Arabia this summer, with more MENA countries in their line of sight over the next three years.

I reckon it’s high time women’s health came out from under the shadows. For ages, issues linked to fertility and hormones have been a bit of a faff to discuss, leading to huge gaps in support and understanding. Ovasave’s approach—cutting costs, raising outcomes, and using smart tech—could finally move the needle.

Investors have started to twig to the opportunities too. According to data from FemTech Analytics, the regional market could balloon to $3.8 billion by 2031, which is definately nothing to sneeze at! All said, Ovasave’s bold moves and glossy new funding round are reminders there’s real appetite to transform women’s health across the region, not just talk about it.

And believe it or not, stories like this are why folks at Arageek keep at it—there’s nothing quite like seeing MENA’s homegrown ventures smashing taboos and raising the bar for healthcare. Bit by bit, the region is proving you can teach old dogs new tricks.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!

✉️ Send Us Your Story 👇

https://en.arageek.com/send-us-your-story-or-a-news-tip